Insider trading activities (stock purchases, sales, and option exercises)
reported by insiders of Biogen Inc. (BIIB)
since 2015 are shown in Table 1 and Table 2.
Table 1 shows the monthly insider trading data of Biogen Inc..
Table 2 shows the detailed insider transactions.
This company's CIK number is 875045.
Total stock buying since 2015: $183,154,843.
Total stock sales since 2015: $66,270,692.
Total stock option exercises since 2015: $8,498,226.
Table 3. Detailed insider trading at Biogen Inc. (BIIB)
| Trade Date |
Insider Name |
Trade Type |
Shares |
Price ($) |
Value ($) |
| 2025-09-02 | Singhal Priya (Head of Development) | Sale | 517 | 133.55 | 69,045 |
| 2025-08-29 | Singhal Priya (Head of Development) | Option Ex | 1,669 | .00 | 0 |
| 2025-07-08 | Izzar Rachid (Head of Global Product Strat.) | Sale | 4,446 | 135.00 | 600,210 |
| 2025-05-02 | Dorsa Caroline (Director) | Buy | 1,235 | 122.72 | 151,559 |
| 2025-05-01 | Keeney Adam (Head of Corporate Development) | Option Ex | 938 | .00 | 0 |
| 2025-03-07 | Sherwin Stephen A (Director) | Sale | 8,760 | 150.02 | 1,314,140 |
| 2025-02-10 | Murphy Nicole (Head of Pharm Ops and Tech) | Option Ex | 2,272 | .00 | 0 |
| 2025-02-10 | Izzar Rachid (Head of Global Product Strat.) | Option Ex | 1,515 | .00 | 0 |
| 2025-02-10 | Singhal Priya (Head of Development) | Option Ex | 1,212 | .00 | 0 |
| 2025-02-10 | Alexander Susan H (EVP Chief Legal Officer) | Option Ex | 2,575 | .00 | 0 |
| 2025-02-07 | Grogan Jane (Head of Research) | Option Ex | 1,385 | .00 | 0 |
| 2025-02-07 | Keeney Adam (Head of Corporate Development) | Option Ex | 1,801 | .00 | 0 |
| 2025-02-07 | Murphy Nicole (Head of Pharm Ops and Tech) | Option Ex | 4,042 | .00 | 0 |
| 2025-02-07 | Izzar Rachid (Head of Global Product Strat.) | Option Ex | 3,844 | .00 | 0 |
| 2025-02-07 | Singhal Priya (Head of Development) | Option Ex | 2,216 | .00 | 0 |
| 2025-02-07 | Kramer Robin (Chief Accounting Officer) | Option Ex | 1,491 | .00 | 0 |
| 2025-02-07 | Gregory Ginger (EVP, Human Resources) | Option Ex | 3,436 | .00 | 0 |
| 2025-02-07 | Alexander Susan H (EVP Chief Legal Officer) | Option Ex | 4,130 | .00 | 0 |
| 2025-02-07 | Mcdonnell Michael R (EVP, Chief Financial Officer) | Option Ex | 4,551 | .00 | 0 |
| 2025-01-31 | Singhal Priya (Head of Development) | Option Ex | 1,828 | .00 | 0 |
| 2024-11-01 | Grogan Jane (Head of Research) | Option Ex | 695 | .00 | 0 |
| 2024-09-03 | Singhal Priya (Head of Development) | Sale | 431 | 204.22 | 88,018 |
| 2024-08-30 | Singhal Priya (Head of Development) | Option Ex | 1,668 | .00 | 0 |
| 2024-05-01 | Keeney Adam (Head of Corporate Development) | Option Ex | 938 | .00 | 0 |
| 2024-04-02 | Singhal Priya (Head of Development) | Sale | 93 | 213.09 | 19,817 |
| 2024-04-01 | Murphy Nicole (Head of Pharm Ops and Tech) | Option Ex | 240 | .00 | 0 |
| 2024-02-22 | Singhal Priya (Head of Development) | Sale | 262 | 221.23 | 57,962 |
| 2024-02-16 | Murphy Nicole (Head of Pharm Ops and Tech) | Option Ex | 1,260 | .00 | 0 |
| 2024-02-16 | Izzar Rachid (Head of Global Product Strat.) | Option Ex | 2,017 | .00 | 0 |
| 2024-02-16 | Singhal Priya (Head of Development) | Sale | 108 | 221.49 | 23,920 |
| 2024-02-16 | Singhal Priya (Head of Development) | Option Ex | 1,208 | .00 | 0 |
| 2024-02-16 | Kramer Robin (Chief Accounting Officer) | Option Ex | 1,345 | .00 | 0 |
| 2024-02-16 | Gregory Ginger (EVP, Human Resources) | Option Ex | 4,704 | .00 | 0 |
| 2024-02-16 | Alexander Susan H (EVP Chief Legal Officer) | Option Ex | 5,037 | .00 | 0 |
| 2024-02-16 | Mcdonnell Michael R (EVP, Chief Financial Officer) | Option Ex | 6,720 | .00 | 0 |
| 2024-02-15 | Rowinsky Eric K (Director) | Buy | 455 | 222.54 | 101,255 |
| 2024-02-12 | Singhal Priya (Head of Development) | Sale | 419 | 239.45 | 100,329 |
| 2024-02-09 | Murphy Nicole (Head of Pharm Ops and Tech) | Option Ex | 2,272 | .00 | 0 |
| 2024-02-09 | Izzar Rachid (Head of Global Product Strat.) | Option Ex | 1,515 | .00 | 0 |
| 2024-02-09 | Singhal Priya (Head of Development) | Option Ex | 1,212 | .00 | 0 |
| 2024-02-09 | Kramer Robin (Chief Accounting Officer) | Option Ex | 833 | .00 | 0 |
| 2024-02-09 | Gregory Ginger (EVP, Human Resources) | Option Ex | 2,158 | .00 | 0 |
| 2024-02-09 | Alexander Susan H (EVP Chief Legal Officer) | Option Ex | 2,575 | .00 | 0 |
| 2024-02-09 | Mcdonnell Michael R (EVP, Chief Financial Officer) | Option Ex | 3,257 | .00 | 0 |
| 2024-02-08 | Murphy Nicole (Head of Pharm Ops and Tech) | Option Ex | 2,101 | .00 | 0 |
| 2024-02-08 | Izzar Rachid (Head of Global Product Strat.) | Option Ex | 2,043 | .00 | 0 |
| 2024-02-08 | Kramer Robin (Chief Accounting Officer) | Option Ex | 788 | .00 | 0 |
| 2024-02-08 | Gregory Ginger (EVP, Human Resources) | Option Ex | 1,635 | .00 | 0 |
| 2024-02-08 | Alexander Susan H (EVP Chief Legal Officer) | Option Ex | 2,190 | .00 | 0 |
| 2024-02-08 | Mcdonnell Michael R (EVP, Chief Financial Officer) | Option Ex | 2,335 | .00 | 0 |
| 2024-02-02 | Singhal Priya (Head of Development) | Sale | 634 | 245.93 | 155,919 |
| 2024-02-01 | Singhal Priya (Head of Development) | Option Ex | 1,828 | .00 | 0 |
| 2023-12-11 | Singhal Priya (Head of Development) | Sale | 110 | 248.00 | 27,280 |
| 2023-12-08 | Singhal Priya (Head of Development) | Option Ex | 426 | .00 | 0 |
| 2023-12-08 | Kramer Robin (Chief Accounting Officer) | Option Ex | 351 | .00 | 0 |
| 2023-09-05 | Singhal Priya (Head of Development) | Sale | 431 | 269.43 | 116,124 |
| 2023-09-01 | Singhal Priya (Head of Development) | Option Ex | 1,668 | .00 | 0 |
| 2023-09-01 | Mcdonnell Michael R (EVP, Chief Financial Officer) | Option Ex | 5,285 | .00 | 0 |
| 2023-07-03 | Singhal Priya (Head of Development) | Sale | 81 | 282.87 | 22,912 |
| 2023-06-30 | Izzar Rachid (Head of Global Product Strat.) | Option Ex | 504 | .00 | 0 |
| 2023-06-30 | Singhal Priya (Head of Development) | Option Ex | 315 | .00 | 0 |
| 2023-06-30 | Kramer Robin (Chief Accounting Officer) | Option Ex | 252 | .00 | 0 |
| 2023-04-28 | Gregory Ginger (EVP, Human Resources) | Sale | 2,681 | 300.00 | 804,300 |
| 2023-04-04 | Singhal Priya (Head of Development) | Sale | 91 | 277.11 | 25,217 |
| 2023-03-31 | Murphy Nicole (Head of Pharm Ops and Tech) | Option Ex | 239 | .00 | 0 |
| 2023-03-28 | Singhal Priya (Head of Development) | Sale | 568 | 270.06 | 153,394 |
| 2023-03-02 | Singhal Priya (Head of Development) | Option Ex | 297 | .00 | 0 |
| 2023-02-17 | Izzar Rachid (Head of Global Product Strat.) | Option Ex | 767 | .00 | 0 |
| 2023-02-17 | Singhal Priya (Head of Development) | Option Ex | 460 | .00 | 0 |
| 2023-02-17 | Kramer Robin (Chief Accounting Officer) | Option Ex | 512 | .00 | 0 |
| 2023-02-17 | Gregory Ginger (EVP, Human Resources) | Option Ex | 1,792 | .00 | 0 |
| 2023-02-17 | Alexander Susan H (EVP Chief Legal Off & Corp Sec) | Option Ex | 1,920 | .00 | 0 |
| 2023-02-17 | Mcdonnell Michael R (EVP, Chief Financial Officer) | Option Ex | 2,561 | .00 | 0 |
| 2023-02-10 | Murphy Nicole (Head of Pharm Ops and Tech) | Option Ex | 2,611 | .00 | 0 |
| 2023-02-10 | Izzar Rachid (Head of Global Product Strat.) | Option Ex | 1,968 | .00 | 0 |
| 2023-02-10 | Singhal Priya (Head of Development) | Option Ex | 1,211 | .00 | 0 |
| 2023-02-10 | Kramer Robin (Chief Accounting Officer) | Option Ex | 1,061 | .00 | 0 |
| 2023-02-10 | Gregory Ginger (EVP, Human Resources) | Option Ex | 3,290 | .00 | 0 |
| 2023-02-10 | Alexander Susan H (EVP Chief Legal Off & Corp Sec) | Option Ex | 4,023 | .00 | 0 |
| 2023-02-10 | Mcdonnell Michael R (EVP, Chief Financial Officer) | Option Ex | 3,256 | .00 | 0 |
| 2022-12-08 | Kramer Robin (Chief Accounting Officer) | Option Ex | 350 | .00 | 0 |
| 2022-12-02 | Murphy Nicole (Head of Pharm Ops and Tech) | Option Ex | 131 | .00 | 0 |
| 2022-12-02 | Izzar Rachid (Head of Alzheimer's Disease) | Option Ex | 1,710 | .00 | 0 |
| 2022-11-14 | Gregory Ginger (EVP, Human Resources) | Sale | 5,610 | 300.11 | 1,683,617 |
| 2022-10-27 | Alexander Susan H (EVP Chief Legal Off & Corp Sec) | Sale | 5,532 | 280.70 | 1,552,832 |
| 2022-09-01 | Mcdonnell Michael R (EVP, Chief Financial Officer) | Option Ex | 4,746 | .00 | 0 |
| 2022-08-01 | Murphy Nicole (Head of Pharm Ops and Tech) | Option Ex | 1,080 | .00 | 0 |
| 2022-07-01 | Izzar Rachid (Head of Alzheimer's Disease) | Option Ex | 504 | .00 | 0 |
| 2022-07-01 | Kramer Robin (Chief Accounting Officer) | Option Ex | 252 | .00 | 0 |
| 2022-04-01 | Murphy Nicole (Head of Pharm Ops and Tech) | Option Ex | 239 | .00 | 0 |
| 2022-02-18 | Murphy Nicole (Head of Pharm Ops and Tech) | Option Ex | 371 | .00 | 0 |
| 2022-02-18 | Izzar Rachid (Head of Alzheimer's Disease) | Option Ex | 594 | .00 | 0 |
| 2022-02-18 | Guindo Chirfi (Head of Glob Prod Strat & Com) | Option Ex | 1,981 | .00 | 0 |
| 2022-02-18 | Vounatsos Michel (Chief Executive Officer) | Option Ex | 6,191 | .00 | 0 |
| 2022-02-18 | Kramer Robin (Chief Accounting Officer) | Option Ex | 396 | .00 | 0 |
| 2022-02-18 | Gregory Ginger (EVP, Human Resources) | Option Ex | 1,387 | .00 | 0 |
| 2022-02-18 | Alexander Susan H (EVP Chief Legal Off & Corp Sec) | Option Ex | 1,485 | .00 | 0 |
| 2022-02-18 | Mcdonnell Michael R (EVP, Chief Financial Officer) | Option Ex | 1,981 | .00 | 0 |
| 2022-02-12 | Murphy Nicole (Head of Pharm Ops and Tech) | Option Ex | 263 | .00 | 0 |
| 2022-02-12 | Izzar Rachid (Head of Alzheimer's Disease) | Option Ex | 351 | .00 | 0 |
| 2022-02-12 | Guindo Chirfi (Head of Glob Prod Strat & Com) | Option Ex | 2,597 | .00 | 0 |
| 2022-02-12 | Vounatsos Michel (Chief Executive Officer) | Option Ex | 8,716 | .00 | 0 |
| 2022-02-12 | Kramer Robin (Chief Accounting Officer) | Option Ex | 275 | .00 | 0 |
| 2022-02-12 | Gregory Ginger (EVP, Human Resources) | Option Ex | 1,672 | .00 | 0 |
| 2022-02-12 | Alexander Susan H (EVP Chief Legal Off & Corp Sec) | Option Ex | 2,280 | .00 | 0 |
| 2021-12-03 | Kramer Robin (Chief Accounting Officer) | Option Ex | 339 | 223.92 | 75,908 |
| 2021-12-02 | Izzar Rachid (Head of Alzheimer's Disease) | Option Ex | 372 | 228.52 | 85,009 |
| 2021-09-01 | Mcdonnell Michael R (EVP, Chief Financial Officer) | Option Ex | 6,005 | 338.24 | 2,031,131 |
| 2021-07-01 | Kramer Robin (Chief Accounting Officer) | Option Ex | 251 | 348.92 | 87,578 |
| 2021-06-04 | Posner Brian S (Director) | Sale | 360 | 274.17 | 98,701 |
| 2021-02-12 | Galdes Alphonse (EVP Pharmaceutical Oper & Tech) | Option Ex | 1,573 | .00 | 0 |
| 2021-02-12 | Guindo Chirfi (EVP Glob. Prod Strat and Comm) | Option Ex | 3,156 | .00 | 0 |
| 2021-02-12 | Vounatsos Michel (Chief Executive Officer) | Option Ex | 16,289 | .00 | 0 |
| 2021-02-12 | Kramer Robin (SVP, Chief Accounting Officer) | Option Ex | 333 | .00 | 0 |
| 2021-02-12 | Sandrock Alfred (EVP, Research & Development) | Option Ex | 4,454 | .00 | 0 |
| 2021-02-12 | Gregory Ginger (EVP, Human Resources) | Option Ex | 2,923 | .00 | 0 |
| 2021-02-12 | Alexander Susan H (EVP Chief Legal Off & Corp Sec) | Option Ex | 4,355 | .00 | 0 |
| 2021-02-09 | Mantas Jesus B (Director) | Buy | 898 | 267.00 | 239,766 |
| 2020-12-03 | Kramer Robin (VP, Chief Accounting Officer) | Option Ex | 74 | .00 | 0 |
| 2020-12-01 | Guindo Chirfi (EVP Glob. Prod Strat and Comm) | Option Ex | 481 | .00 | 0 |
| 2020-11-30 | Vounatsos Michel (Chief Executive Officer) | Buy | 3,100 | 241.31 | 748,045 |
| 2020-11-04 | Sandrock Alfred (EVP, Research & Development) | Sale | 1,500 | 350.00 | 525,000 |
| 2020-07-31 | Gregory Ginger (EVP, Human Resources) | Option Ex | 212 | .00 | 0 |
| 2020-03-11 | Sherwin Stephen A (Director) | Sale | 2,434 | 295.25 | 718,645 |
| 2020-03-11 | Sherwin Stephen A (Director) | Option Ex | 12,278 | 58.46 | 717,771 |
| 2020-02-15 | Galdes Alphonse (EVP Pharmaceutical Oper & Tech) | Option Ex | 441 | .00 | 0 |
| 2020-02-15 | Vounatsos Michel (Chief Executive Officer) | Option Ex | 4,847 | .00 | 0 |
| 2020-02-15 | Sandrock Alfred (EVP, Research & Development) | Option Ex | 1,213 | .00 | 0 |
| 2020-02-15 | Alexander Susan H (EVP Chief Legal Off & Corp Sec) | Option Ex | 1,553 | .00 | 0 |
| 2020-02-12 | Galdes Alphonse (EVP Pharmaceutical Oper & Tech) | Option Ex | 1,154 | .00 | 0 |
| 2020-02-12 | Karp Daniel (EVP, Corporate Development) | Option Ex | 960 | .00 | 0 |
| 2020-02-12 | Guindo Chirfi (EVP Glob. Prod Strat and Comm) | Option Ex | 1,680 | .00 | 0 |
| 2020-02-12 | Vounatsos Michel (Chief Executive Officer) | Option Ex | 11,994 | .00 | 0 |
| 2020-02-12 | Kramer Robin (VP, Chief Accounting Officer) | Option Ex | 132 | .00 | 0 |
| 2020-02-12 | Sandrock Alfred (EVP, Research & Development) | Option Ex | 5,216 | .00 | 0 |
| 2020-02-12 | Gregory Ginger (EVP, Human Resources) | Option Ex | 3,547 | .00 | 0 |
| 2020-02-12 | Alexander Susan H (EVP Chief Legal Off & Corp Sec) | Option Ex | 5,967 | .00 | 0 |
| 2020-02-12 | Capello Jeffrey D (EVP & Chief Financial Officer) | Option Ex | 1,919 | .00 | 0 |
| 2020-01-02 | Capello Jeffrey D (EVP & Chief Financial Officer) | Option Ex | 1,302 | .00 | 0 |
| 2019-12-03 | Kramer Robin (VP, Chief Accounting Officer) | Option Ex | 84 | .00 | 0 |
| 2019-12-02 | Posner Brian S (Director) | Sale | 1,055 | 292.35 | 308,429 |
| 2019-12-01 | Guindo Chirfi (EVP Glob. Prod Strat and Comm) | Option Ex | 543 | .00 | 0 |
| 2019-08-01 | Gregory Ginger (EVP, Human Resources) | Option Ex | 179 | .00 | 0 |
| 2019-07-02 | Karp Daniel (EVP, Corporate Development) | Option Ex | 196 | .00 | 0 |
| 2019-06-01 | Ehlers Michael D (EVP, Research and Development) | Option Ex | 1,126 | .00 | 0 |
| 2019-05-02 | Vounatsos Michel (Chief Executive Officer) | Option Ex | 1,480 | .00 | 0 |
| 2019-05-02 | Denner Alexander J (Director) | Buy | 38,000 | 231.24 | 8,787,120 |
| 2019-05-01 | Vounatsos Michel (Chief Executive Officer) | Buy | 4,351 | 231.48 | 1,007,169 |
| 2019-05-01 | Denner Alexander J (Director) | Buy | 30,000 | 229.46 | 6,883,800 |
| 2019-04-30 | Denner Alexander J (Director) | Buy | 50,342 | 229.25 | 11,540,903 |
Insider trading activities including stock purchases, stock sales, and option exercises
of BIIB listed in the above tables cannot be completely guaranteed as to their accuracy.
For more insider trading information of Biogen Inc. (symbol BIIB,
CIK number 875045) see
the Securities and Exchange Commission (SEC) website.